Home / Lifestyle / Health & Fitness / Article / Reliance-Backed Strand Life Sciences bags Indian patent for AI-powered blood test to detect cancer early

Reliance-Backed Strand Life Sciences bags Indian patent for AI-powered blood test to detect cancer early

The patented technology analyses cell-free DNA from a simple blood sample to identify early signs of cancer and predict its tissue of origin, offering hope for faster, more accessible and scalable screening

  • WhatsAppBookmarkBookmark
Listen to this article :
Reliance subsidiary develops AI-based blood test for early cancer detection (Pic/Special arrangement)

Reliance subsidiary develops AI-based blood test for early cancer detection (Pic/Special arrangement)

In a significant step towards advancing early cancer detection in India, Strand Life Sciences, a subsidiary of Reliance Industries Limited, has been granted an Indian patent for an integrated platform that uses artificial intelligence (AI) and cell-free DNA (cfDNA) analysis to detect cancer from a simple blood sample.

The patented technology combines high-quality genome sequencing, stringent quality control, methylation and fragmentomic analysis, and machine learning algorithms to identify early cancer-related changes in DNA circulating in the bloodstream. It can also predict the tissue of origin of the cancer, enabling doctors to investigate the affected organ at an earlier stage.

Read Next Story
Researchers make fascinating discovery as they identify two types of laughter in humans›

Trending Stories

Latest Photoscta-pos

Latest VideosView All

Latest Web StoriesView All

Mid-Day FastView All